Rashtriya Newsflash

Open-Angle Glaucoma Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Open-Angle Glaucoma Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Open-Angle Glaucoma clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline Open-Angle Glaucoma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 28,

Read Full Article

Myotonic Dystrophy Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Myotonic Dystrophy clinical trial analysis report delivers important insights into ongoing research of 22+ pipeline Myotonic Dystrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 28,

Read Full Article

Arshiner Expands “Spooktacularly You” Campaign with Halloween Loungewear and Performance Dance Costumes

NEW YORK, NY – September 29, 2026 – Premier juvenile apparel manufacturer Arshiner has officially expanded its “Spooktacularly You” Halloween product initiative across North America. Engineered to accommodate early-October holiday purchasing

Read Full Article

Systemic Lupus Erythematosus Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Systemic Lupus Erythematosus Clinical Trials analysis report delivers important insights into ongoing research of 120+ pipeline Systemic Lupus Erythematosus Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)

Read Full Article

Amyotrophic Lateral Sclerosis Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Amyotrophic Lateral Sclerosis Clinical Trials analysis report delivers important insights into ongoing research on 80+ pipeline Amyotrophic Lateral Sclerosis

Read Full Article

Somatotropin Deficiency Clinical Trial Pipeline Gains Momentum: 4+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Somatotropin Deficiency Clinical Trials analysis report delivers important insights into ongoing research of 4+ pipeline Somatotropin Deficiency Drugs, clinical

Read Full Article

Chronic Pain Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Therapeutics Landscape

The Chronic Pain Clinical Trials analysis report delivers important insights into ongoing research on 15+ pipeline Chronic Pain Drugs, clinical

Read Full Article

Acute Myeloid Leukemia Clinical Trial Drug Development Pipeline Expands with Contributions from 100+ Key Companies | DelveInsight

The Acute Myeloid Leukemia Clinical Trials analysis report delivers important insights into ongoing research of 100+ pipeline Acute Myeloid Leukemia

Read Full Article

Epilepsy Treatment Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Epilepsy Clinical Trials analysis report delivers important insights into ongoing research of 75+ pipeline Epilepsy Drugs, clinical strategies, upcoming

Read Full Article

Multiple System Atrophy Clinical Trial Pipeline Appears Robust With 22+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Multiple System Atrophy Clinical Trials analysis report delivers important insights into ongoing research of 22+ pipeline Multiple System Atrophy

Read Full Article